Altre lingue Structure Therapeutics Inc.

Azioni

GPCR

US86366E1064

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 10/05/2024			Variaz. 5gg	Var. 1 gen.
35,82 ^USD	-7,32%		-8,83%	-12,12%

09/05	Structure Therapeutics Inc. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
09/04	STRUCTURE THERAPEUTICS INC. : Cantor Fitzgerald mantiene la raccomandazione Buy	ZM

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Structure Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Structure Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights	09/05
ADRs Edge Higher; Lufax Climbs Almost 46%	21/03
Structure Therapeutics to Present at Leerink Partners Global Biopharma Conference	11/03
Structure Therapeutics to Present at Leerink Partners Global Biopharma Conference	08/03
Structure Therapeutics Q4 Loss Widens	08/03
Structure Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	08/03
Structure Therapeutics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	08/03
Structure Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Highlights	08/03
Health Care Down on Growth Bias -- Health Care Roundup	19/12
ADRs Advance, Fanhua Inc. Climbs 26.7%	18/12
Structure Therapeutics Shares Tumble After Update on GSBR-1290 for Weight Loss	18/12
Structure's diabetes pill misses weight-loss expectations in mid-stage trial	18/12
Structure Therapeutics Inc. Provides Comprehensive GSBR-1290 Program Update	18/12
Structure Therapeutics Provides Comprehensive GSBR-1290 Program Update Including Clinically Meaningful Proof-of-Concept Data From Phase 2a Clinical Study	18/12
Structure Therapeutics Provides Comprehensive GSBR-1290 Program Update Including Clinically Meaningful Proof-of-Concept Data From Phase 2a Clinical Study	18/12
Structure Therapeutics Inc.(NasdaqGM:GPCR) added to NASDAQ Biotechnology Index	18/12
ADRs Slump; FLJ Group Ltd. Declines 13.7%	15/11
Structure Therapeutics Q3 Loss Narrows	14/11
Structure Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Structure Therapeutics Inc.

Azioni

GPCR

US86366E1064

Altre lingue

Filtri